1. Home
  2. HALO vs REXR Comparison

HALO vs REXR Comparison

Compare HALO & REXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • REXR
  • Stock Information
  • Founded
  • HALO 1998
  • REXR 2013
  • Country
  • HALO United States
  • REXR United States
  • Employees
  • HALO N/A
  • REXR N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • REXR Real Estate Investment Trusts
  • Sector
  • HALO Health Care
  • REXR Real Estate
  • Exchange
  • HALO Nasdaq
  • REXR Nasdaq
  • Market Cap
  • HALO 7.6B
  • REXR 8.6B
  • IPO Year
  • HALO N/A
  • REXR 2013
  • Fundamental
  • Price
  • HALO $75.85
  • REXR $42.80
  • Analyst Decision
  • HALO Buy
  • REXR Hold
  • Analyst Count
  • HALO 8
  • REXR 9
  • Target Price
  • HALO $70.25
  • REXR $40.78
  • AVG Volume (30 Days)
  • HALO 1.9M
  • REXR 2.8M
  • Earning Date
  • HALO 10-30-2025
  • REXR 10-15-2025
  • Dividend Yield
  • HALO N/A
  • REXR 4.02%
  • EPS Growth
  • HALO 68.93
  • REXR 11.21
  • EPS
  • HALO 4.37
  • REXR 1.35
  • Revenue
  • HALO $1,178,672,000.00
  • REXR $986,532,000.00
  • Revenue This Year
  • HALO $32.57
  • REXR $9.35
  • Revenue Next Year
  • HALO $23.25
  • REXR $6.25
  • P/E Ratio
  • HALO $17.35
  • REXR $31.79
  • Revenue Growth
  • HALO 34.97
  • REXR 13.72
  • 52 Week Low
  • HALO $42.01
  • REXR $29.68
  • 52 Week High
  • HALO $77.60
  • REXR $52.37
  • Technical
  • Relative Strength Index (RSI)
  • HALO 53.16
  • REXR 52.86
  • Support Level
  • HALO N/A
  • REXR N/A
  • Resistance Level
  • HALO $77.60
  • REXR $43.79
  • Average True Range (ATR)
  • HALO 1.53
  • REXR 0.75
  • MACD
  • HALO -3.05
  • REXR -1.54
  • Stochastic Oscillator
  • HALO 97.74
  • REXR 97.74

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About REXR Rexford Industrial Realty Inc.

Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.

Share on Social Networks: